Tuesday, March 24, 2020

Tarrytown, New York-Based Regeneron Pharmaceuticals' Top-Tier Executives Average Annual Pay and Benefits Increase During the Past Ten Years Was a Blistering 57.0% Per Year

From Company Proxy Statement filings with the SEC, below are Regeneron Pharmaceuticals Inc's Top-Tier Executives Annual Total Compensation for each of two consecutive full years of employment for the most recent ten years.


  FYE FYE FYE FYE FYE FYE FYE FYE FYE FYE
Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec
Regeneron Pharmaceuticals 2018 2017 2017 2016 2016 2015 2015 2014 2014 2013
Top-Tier Total Total Total Total Total Total Total Total Total Total
Executive Comp Comp Comp Comp Comp Comp Comp Comp Comp Comp
$ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s
 Schleifer CEO      26,521     26,508     26,508     28,338     28,338     47,463     47,463     41,965     41,965     36,273
 Yancopoulos Chief Scientific Officer      25,381     25,299     25,299     27,768     27,768     40,302     40,302     35,507     35,507     31,018
 Landry CFO        9,357       4,795       4,795       5,165       5,165       8,249       8,249       7,373  N/A   N/A 
 Van Plew        9,007       8,979
 Stahl EVP R&D        9,137     10,985     10,985     18,375     18,375     16,254     16,254     14,355
 Terifay        6,771     11,157     11,157       8,396       8,396       7,679
        70,266     65,581     65,739     72,256     79,027   125,546   125,546   109,495   102,122     89,325
Annual % Change vs Prior Year 7.1% -9.0% -37.1% 14.7% 14.3%
5 Year Average Per Year % Change -2.0%
  FYE FYE FYE FYE FYE FYE FYE FYE FYE FYE
Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec
Regeneron Pharmaceuticals 2013 2012 2012 2011 2011 2010 2010 2009 2009 2008
Top-Tier Total Total Total Total Total Total Total Total Total Total
Executive Comp Comp Comp Comp Comp Comp Comp Comp Comp Comp
$ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s $ 000s
 Schleifer CEO      36,273     30,047     30,047     10,563     10,563       7,588       7,588       6,349       6,349       2,554
 Yancopoulos Chief Scientific Officer      31,018     81,551     81,551     10,027     10,027     13,352     13,352       5,108       5,108       1,944
 Landry CFO   N/A   N/A     
 Van Plew 
 Stahl EVP R&D      14,355     11,995     11,995       3,150       3,150       4,520       4,520       2,867       2,867       1,102
 Terifay        7,679       7,478    
 Goldberg        2,711       9,623       9,623       3,106       3,106       3,638       3,638       2,015       2,015          993
 Totals      92,036   140,694   133,216     26,846     26,846     29,098     29,098     16,339     16,339       6,593
Annual % Change vs Prior Year -34.6% 396.2% -7.7% 78.1% 147.8%
5 Year Average Per Year % Change 116.0%
5 Year Average Per Year % Change 57.0%